{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T16:59:32Z","timestamp":1790441972883,"version":"4.1.0"},"reference-count":152,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003093","name":"Ministry of Higher Education, Malaysia","doi-asserted-by":"publisher","award":["FRGS\/1\/2024\/SKKO3\/USM\/02\/1"],"award-info":[{"award-number":["FRGS\/1\/2024\/SKKO3\/USM\/02\/1"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ijbiomac.2026.152755","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T07:00:05Z","timestamp":1779951605000},"page":"152755","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development and characterization of novel T-cell receptor\u2013like antibodies targeting human papillomavirus type 16 oncoprotein peptides for early cervical cancer detection using experimental and computational approaches"],"prefix":"10.1016","volume":"370","author":[{"given":"Bassam Ali","family":"Sachit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Dass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehasri Selva","family":"Rajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gee Jun","family":"Tye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venugopal","family":"Balakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152755_bb0005","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ijc.35369","article-title":"Global landscape of cervical cancer incidence and mortality in 2022 and predictions to 2030: The urgent need to address inequalities in cervical cancer","volume":"157","author":"Li","year":"2025","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ijbiomac.2026.152755_bb0010","first-page":"1","article-title":"Cancer stages and demographical study of HPV16 in gene L2 isolated from cervical cancer in Dhi-Qar province, Iraq","volume":"12","author":"Jalil","year":"2021","journal-title":"Appl. Nanosci."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.152755_bb0015","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/mc.23292","article-title":"HPV-16\/18 E6-induced APOBEC3B expression associates with proliferation of cervical cancer cells and hypomethylation of Cyclin D1","volume":"60","author":"Fan","year":"2021","journal-title":"Mol. Carcinog."},{"issue":"39","key":"10.1016\/j.ijbiomac.2026.152755_bb0020","doi-asserted-by":"crossref","first-page":"8163","DOI":"10.2174\/0929867327666201111145546","article-title":"E6 and E7 oncoproteins: potential targets of cervical cancer","volume":"28","author":"Malla","year":"2021","journal-title":"Curr. Med. Chem."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.152755_bb0025","doi-asserted-by":"crossref","first-page":"276","DOI":"10.4236\/ajmb.2023.134019","article-title":"Detection of Human Papillomavirus DNA and E6\/E7 mRNA from HPV genotypes 16, 18, 31 and 33 in histologically confirmed cases of cervical cancer and precancerous lesions in Burkina Faso","volume":"13","author":"Zohoncon","year":"2023","journal-title":"Am J Mol Biol"},{"key":"10.1016\/j.ijbiomac.2026.152755_bb0030","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10989-020-10089-5","article-title":"HPV16-E7 protein T cell epitope prediction and global therapeutic peptide vaccine design based on human leukocyte antigen frequency: an in-silico study","volume":"27","author":"Bahmani","year":"2021","journal-title":"Int. J. Pept. Res. Ther."},{"key":"10.1016\/j.ijbiomac.2026.152755_bb0035","first-page":"107","article-title":"Designing of CD8+ and CD8+-overlapped CD4+ epitope vaccine by targeting late and early proteins of human papillomavirus","author":"Kaliamurthi","year":"2018","journal-title":"Biologics (Auckl)."},{"key":"10.1016\/j.ijbiomac.2026.152755_bb0040","article-title":"Cytology versus HPV testing for cervical cancer screening in the general population","volume":"8","author":"Koliopoulos","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"issue":"14","key":"10.1016\/j.ijbiomac.2026.152755_bb0045","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/jnci\/dji186","article-title":"Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities","volume":"97","author":"Castle","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ijbiomac.2026.152755_bb0050","article-title":"Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions","volume":"3","author":"Arbyn","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.152755_bb0055","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1128\/JCM.00265-12","article-title":"Cytology and human papillomavirus testing 6 to 12 months after ASCUS or LSIL cytology in organized screening to predict high-grade cervical neoplasia between screening rounds","volume":"50","author":"Trop\u00e9","year":"2012","journal-title":"J. Clin. Microbiol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152755_bb0060","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/ijc.28984","article-title":"Long-term HPV type-specific risks for ASCUS and LSIL: a 14-year follow-up of a randomized primary HPV screening trial","volume":"136","author":"Elfstr\u00f6m","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152755_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4274\/jtgga.2016.0138","article-title":"Do clinical data and human papilloma virus genotype influence spontaneous regression in grade I cervical intraepithelial neoplasia?","volume":"18","author":"Cort\u00e9s-Alaguero","year":"2017","journal-title":"Journal of the Turkish German Gynecological Association"},{"issue":"17","key":"10.1016\/j.ijbiomac.2026.152755_bb0070","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/jnci\/djg037","article-title":"Human papillomavirus infection and time to progression and regression of Cervical Intraepithelial Neoplasia","volume":"95","author":"Schlecht","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"issue":"20","key":"10.1016\/j.ijbiomac.2026.152755_bb0075","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1056\/NEJMp058171","article-title":"The promise of global cervical-cancer prevention","volume":"353","author":"Schiffman","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.ijbiomac.2026.152755_bb0080","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1056\/NEJMsa044278","article-title":"Cost-effectiveness of cervical-cancer screening in five developing countries","volume":"353","author":"Goldie","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.ijbiomac.2026.152755_bb0085","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1056\/NEJMoa0808516","article-title":"HPV screening for cervical cancer in rural India","volume":"360","author":"Sankaranarayanan","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.152755_bb0090","doi-asserted-by":"crossref","first-page":"853","DOI":"10.31557\/APJCP.2020.21.3.853","article-title":"Effectiveness of a health education program to improve knowledge and attitude towards cervical cancer and pap smear: a controlled community trial in Malaysia","volume":"21","author":"Romli","year":"2020","journal-title":"Asian Pacific Journal of Cancer Prevention"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.152755_bb0095","doi-asserted-by":"crossref","first-page":"281","DOI":"10.5306\/wjco.v6.i6.281","article-title":"Cervical cancer screening in developing countries at a crossroad: emerging technologies and policy choices","volume":"6","author":"Catarino","year":"2015","journal-title":"World Journal of Clinical Oncology"},{"key":"10.1016\/j.ijbiomac.2026.152755_bb0100","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.gore.2018.02.004","article-title":"The value of visual inspection with acetic acid and Pap smear in cervical cancer screening program in low resource settings\u2013a population-based study","volume":"24","author":"Huy","year":"2018","journal-title":"Gynecologic Oncology Reports"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152755_bb0105","article-title":"Screening for cervical cancer using automated analysis of PAP-smears","volume":"2014","author":"Bengtsson","year":"2014","journal-title":"Comput. Math. Methods Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152755_bb0110","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4103\/JCLGTP.JCLGTP_11_24","article-title":"Role of conventional Pap smear in current times","volume":"2","author":"Kumar","year":"2024","journal-title":"Journal of Colposcopy and Lower Genital Tract Pathology"},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.152755_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188592","article-title":"Human papillomavirus DNA detection in plasma and cervical samples of women with a recent history of low grade or precancerous cervical dysplasia","volume":"12","author":"Cocuzza","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2026.152755_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.624230","article-title":"T cell receptor repertoires acquired via routine pap testing may help refine cervical cancer and precancer risk estimates","volume":"12","author":"Christley","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152755_bb0125","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12929-022-00864-5","article-title":"Identification of human MHC-I HPV18 E6\/E7-specific CD8+ T cell epitopes and generation of an HPV18 E6\/E7-expressing adenosquamous carcinoma in HLA-A2 transgenic mice","volume":"29","author":"Peng","year":"2022","journal-title":"J. Biomed. Sci."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.152755_bb0130","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1002\/ijc.32156","article-title":"Performance of an HPV 16\/18 E6 oncoprotein test for detection of cervical precancer and cancer","volume":"145","author":"Ferrera","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ijbiomac.2026.152755_bb0135","series-title":"Glutathione transferases with novel active sites isolated by phage display from a library of random mutants","first-page":"115","author":"Widersten","year":"1995"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.152755_bb0140","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1074\/jbc.M411047200","article-title":"A novel peptide isolated from a phage display peptide library with trastuzumab can mimic antigen epitope of HER-2","volume":"280","author":"Jiang","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.152755_bb0145","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1248\/bpb.29.1570","article-title":"Creation of novel protein transduction domain (PTD) mutants by a phage display-based high-throughput screening system","volume":"29","author":"Mukai","year":"2006","journal-title":"Biol. Pharm. Bull."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152755_bb0150","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1074\/jbc.M707933200","article-title":"Creation and X-ray structure analysis of the tumor necrosis factor receptor-1-selective mutant of a tumor necrosis factor-\u03b1 antagonist","volume":"283","author":"Shibata","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.152755_bb0155","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1096\/fj.12-224667","article-title":"Identification of a novel CD40 ligand for targeted imaging of inflammatory plaques by phage display","volume":"27","author":"Yu","year":"2013","journal-title":"FASEB J."},{"issue":"15","key":"10.1016\/j.ijbiomac.2026.152755_bb0160","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1158\/1078-0432.CCR-16-3217","article-title":"Identification of a novel ITG\u03b1v\u03b26-binding peptide using protein separation and phage display","volume":"23","author":"Altmann","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152755_bb0165","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3390\/v13020178","article-title":"Phage display technology as a powerful platform for antibody drug discovery","volume":"13","author":"Nagano","year":"2021","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152755_bb0170","doi-asserted-by":"crossref","DOI":"10.1038\/jid.2013.521","article-title":"Antibody phage display: technique and applications","volume":"134","author":"Hammers","year":"2014","journal-title":"J. Invest. Dermatol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.152755_bb0175","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3390\/antib2030517","article-title":"T-cell receptor-like antibodies: targeting the intracellular proteome therapeutic potential and clinical applications","volume":"2","author":"Cohen","year":"2013","journal-title":"Antibodies"},{"key":"10.1016\/j.ijbiomac.2026.152755_bb0180","first-page":"22","article-title":"Preparation of calcium competent Escherichia coli and heat-shock transformation","volume":"1","author":"Chang","year":"2017","journal-title":"JEMI Methods"},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.152755_bb0185","article-title":"Preparing plasmid DNA from bacteria","volume":"2022","author":"Figueroa-Bossi","year":"2022","journal-title":"Cold Spring Harb. Protoc."},{"key":"10.1016\/j.ijbiomac.2026.152755_bb0190","series-title":"AIP Conference Proceedings","doi-asserted-by":"crossref","DOI":"10.1063\/5.0199141","article-title":"The CRISPR\/Cas9-mediated base editing design of HBV specific gRNA: a computational approach","author":"Yuliawuri","year":"2024"},{"issue":"D1","key":"10.1016\/j.ijbiomac.2026.152755_bb0195","doi-asserted-by":"crossref","first-page":"D413","DOI":"10.1093\/nar\/gku1056","article-title":"IMGT\u00ae, the international ImMunoGeneTics information system\u00ae 25 years on","volume":"43","author":"Lefranc","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"10.1016\/j.ijbiomac.2026.152755_bb0200","doi-asserted-by":"crossref","first-page":"W318","DOI":"10.1093\/nar\/gkae270","article-title":"The structure assessment web server: for proteins, complexes and more","volume":"52","author":"Waterhouse","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2026.152755_bb0205","series-title":"The Proteomics Protocols Handbook","first-page":"571","article-title":"Protein identification and analysis tools on the ExPASy server","author":"Gasteiger","year":"2005"},{"key":"10.1016\/j.ijbiomac.2026.152755_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2020.107209","article-title":"Designing a potent L1 protein-based HPV peptide vaccine: a bioinformatics approach","volume":"85","author":"Yazdani","year":"2020","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2026.152755_bb0215","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s002510050595","article-title":"SYFPEITHI: database for MHC ligands and peptide motifs","volume":"50","author":"Rammensee","year":"1999","journal-title":"Immunogenetics"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152755_bb0220","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nprot.2016.169","article-title":"The ClusPro web server for protein\u2013protein docking","volume":"12","author":"Kozakov","year":"2017","journal-title":"Nat. Protoc."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.152755_bb0225","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4473","article-title":"PDBsum 1: a standalone program for generating PDBsum analyses","volume":"31","author":"Laskowski","year":"2022","journal-title":"Protein Sci."},{"key":"10.1016\/j.ijbiomac.2026.152755_bb0230","first-page":"154","article-title":"In silico molecular docking analysis of limonene with the fat mass and obesity-associated protein by using Autodock Vina","volume":"8","author":"Ahmed","year":"2021","journal-title":"Sci J Informatics"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.152755_bb0235","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/nprot.2006.121","article-title":"Generation of peptide\u2013MHC class I complexes through UV-mediated ligand exchange","volume":"1","author":"Rodenko","year":"2006","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152755_bb0240","doi-asserted-by":"crossref","DOI":"10.1002\/cpim.85","article-title":"Production and thermal exchange of conditional peptide-MHC I multimers","volume":"126","author":"Luimstra","year":"2019","journal-title":"Curr. Protoc. Immunol."},{"key":"10.1016\/j.ijbiomac.2026.152755_bb0245","series-title":"Protein Electrophoresis: Methods and Protocols","first-page":"49","article-title":"Native polyacrylamide gels","author":"Arndt","year":"2012"},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.152755_bb0250","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1038\/nprot.2007.448","article-title":"Selection of human antibody fragments by phage display","volume":"2","author":"Lee","year":"2007","journal-title":"Nat. Protoc."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.152755_bb0255","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/protein\/gzm037","article-title":"Repertoires of aggregation-resistant human antibody domains","volume":"20","author":"Christ","year":"2007","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.ijbiomac.2026.152755_bb0260","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ijbiomac.2020.03.229","article-title":"TCR-like domain antibody against Mycobacterium tuberculosis (Mtb) heat shock protein antigen presented by HLA-A* 11 and HLA-A* 24","volume":"155","author":"Dass","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2026.152755_bb0265","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.molimm.2018.07.001","article-title":"Generation of a T cell receptor (TCR)-like single domain antibody (sDAb) against a Mycobacterium tuberculosis (Mtb) heat shock protein (HSP) 16kDa antigen presented by Human Leukocyte Antigen (HLA)-A* 02","volume":"101","author":"Dass","year":"2018","journal-title":"Mol. Immunol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.152755_bb0270","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1080\/08820139.2024.2383736","article-title":"Invariant VD and DJ motifs define a novel class of human antibodies and TCRs prototyped by antigen receptors of dual-expresser lymphocytes","volume":"53","author":"Majety","year":"2024","journal-title":"Immunol. Investig."},{"key":"10.1016\/j.ijbiomac.2026.152755_bb0275","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2024.1468890","article-title":"Machine learning tools used for mapping some immunogenic epitopes within the major structural proteins of the bovine coronavirus (BCoV) and for the in silico design of the multiepitope-based vaccines","volume":"11","author":"Duraisamy","year":"2024","journal-title":"Front. Vet. Sci."},{"issue":"18","key":"10.1016\/j.ijbiomac.2026.152755_bb0280","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1002\/cbic.202100257","article-title":"Evaluation of an E. coli cell extract prepared by lysozyme-assisted sonication via gene expression, phage assembly and proteomics","volume":"22","author":"Falgenhauer","year":"2021","journal-title":"ChemBioChem"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152755_bb0285","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nprot.2011.448","article-title":"Expression of high-affinity human antibody fragments in bacteria","volume":"7","author":"Rouet","year":"2012","journal-title":"Nat. Protoc."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.152755_bb0290","doi-asserted-by":"crossref","first-page":"253","DOI":"10.21873\/cgp.20036","article-title":"Proteomic analysis of normal and cancer cervical cell lines reveals deregulation of cytoskeleton-associated proteins","volume":"14","author":"Pappa","year":"2017","journal-title":"Cancer Genomics Proteomics"},{"key":"10.1016\/j.ijbiomac.2026.152755_bb0295","series-title":"Glutamate Receptors: Methods and Protocols","first-page":"47","article-title":"Cell-based enzyme-linked immunosorbent assay (Cell-ELISA) analysis of native and recombinant glutamate receptors","author":"Moln\u00e1r","year":"2019"},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.152755_bb0300","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24076311","article-title":"Quantum mechanical assessment of protein\u2013ligand hydrogen bond strength patterns: insights from semiempirical tight-binding and local vibrational mode theory","volume":"24","author":"Madushanka","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.152755_bb0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.crstbi.2020.11.002","article-title":"Peptide bond planarity constrains hydrogen bond geometry and influences secondary structure conformations","volume":"3","author":"Tan","year":"2021","journal-title":"Current Research in Structural Biology"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152755_bb0310","first-page":"59","article-title":"Machine learning models for hydrogen bond donor and acceptor strengths using large and diverse training data generated by first-principles interaction free energies","volume":"11","author":"Bauer","year":"2019","journal-title":"J. Chem."},{"issue":"19","key":"10.1016\/j.ijbiomac.2026.152755_bb0315","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1158\/1078-0432.CCR-14-3341","article-title":"Targeting of HPV-16+ epithelial cancer cells by TCR gene engineered T cells directed against E6","volume":"21","author":"Draper","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2026.152755_bb0320","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.molimm.2024.05.006","article-title":"Identification of HPV-E7 specific TCRs for tumor immunotherapy","volume":"171","author":"Li","year":"2024","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ijbiomac.2026.152755_bb0325","series-title":"The Cell: a Molecular Approach","author":"Cooper","year":"2022"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152755_bb0330","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2174\/157489307779314302","article-title":"IMGT Colliers de Perles: standardized sequence-structure representations of the IgSF and MhcSF superfamily domains","volume":"2","author":"Kaas","year":"2007","journal-title":"Curr. Bioinforma."},{"issue":"suppl_1","key":"10.1016\/j.ijbiomac.2026.152755_bb0335","doi-asserted-by":"crossref","first-page":"D208","DOI":"10.1093\/nar\/gkh042","article-title":"IMGT\/3Dstructure-DB and IMGT\/StructuralQuery, a database and a tool for immunoglobulin, T cell receptor and MHC structural data","volume":"32","author":"Kaas","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2026.152755_bb0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12865-017-0218-8","article-title":"IG and TR single chain fragment variable (scFv) sequence analysis: a new advanced functionality of IMGT\/V-QUEST and IMGT\/HighV-QUEST","volume":"18","author":"Giudicelli","year":"2017","journal-title":"BMC Immunol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.152755_bb0345","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3390\/biomedicines8090319","article-title":"Immunoglobulins or antibodies: IMGT\u00ae bridging genes, structures and functions","volume":"8","author":"Lefranc","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.ijbiomac.2026.152755_bb0350","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.707473","article-title":"Tyrosine kinase inhibitors stimulate HLA class I expression by augmenting the IFN\u03b3\/STAT1 signaling in hepatocellular carcinoma cells","volume":"11","author":"Takahashi","year":"2021","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152755_bb0355","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1101\/gr.164806.113","article-title":"Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability","volume":"24","author":"Akagi","year":"2014","journal-title":"Genome Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152755_bb0360","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13073-015-0240-5","article-title":"TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression","volume":"7","author":"Scholtalbers","year":"2015","journal-title":"Genome Med."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.152755_bb0365","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004790","article-title":"Identification of novel HLA-A* 11: 01-restricted HPV16 E6\/E7 epitopes and T-cell receptors for HPV-related cancer immunotherapy","volume":"10","author":"Xiong","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.152755_bb0370","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.drudis.2019.07.011","article-title":"Cervical cancer and HPV infection: ongoing therapeutic research to counteract the action of E6 and E7 oncoproteins","volume":"24","author":"Almeida","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijbiomac.2026.152755_bb0375","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jviromet.2015.03.008","article-title":"Identification of human papillomavirus-16 E6 variation in cervical cancer and their impact on T and B cell epitopes","volume":"218","author":"Kumar","year":"2015","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.ijbiomac.2026.152755_bb0380","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1296948","article-title":"T-cell receptor determinants of response to chemoradiation in locally-advanced HPV16-driven malignancies","volume":"13","author":"Nenclares","year":"2024","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.152755_bb0385","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines12040392","article-title":"Immunoinformatics design and in vivo immunogenicity evaluation of a conserved CTL multi-epitope vaccine targeting HPV16 E5, E6, and E7 proteins","volume":"12","author":"Guo","year":"2024","journal-title":"Vaccines"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.152755_bb0390","article-title":"A novel therapeutic multiepitope vaccine based on oncoprotein E6 and E7 of HPV 16 and 18: An in silico approach","volume":"14","author":"Pratiwi","year":"2024","journal-title":"Bioimpacts"},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.152755_bb0395","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205933","article-title":"A comprehensive in silico analysis for identification of therapeutic epitopes in HPV16, 18, 31 and 45 oncoproteins","volume":"13","author":"Panahi","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2026.152755_bb0400","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.03000","article-title":"Antigenic peptide prediction from E6 and E7 oncoproteins of HPV types 16 and 18 for therapeutic vaccine design using immunoinformatics and MD simulation analysis","volume":"9","author":"Jabbar","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2026.152755_bb0405","series-title":"Identification and biological validation of HPV16 E6\/E7-derived T cell target epitopes and their use for performance assessment of MHC class I binding predictors","author":"Bonsack","year":"2020"},{"issue":"18","key":"10.1016\/j.ijbiomac.2026.152755_bb0410","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.vaccine.2013.02.065","article-title":"HPV-16 E6 and E7 protein T cell epitopes prediction analysis based on distributions of HLA-A loci across populations: an in silico approach","volume":"31","author":"Yao","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2026.152755_bb0415","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-540-73259-4_1","article-title":"Historical development of monoclonal antibody therapeutics","author":"Nissim","year":"2008","journal-title":"Therapeutic Antibodies"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.152755_bb0420","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1006\/clim.2001.5126","article-title":"Identification of peptide sequences specific for serum antibodies from human papillomavirus-infected patients using phage display libraries","volume":"101","author":"Santamaria","year":"2001","journal-title":"Clin. Immunol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.152755_bb0425","article-title":"Identification of a novel targeting peptide for cervical clear cell adenocarcinoma by in vivo phage display screening combined with immunofluorescent analysis","volume":"46","author":"Yang","year":"2025","journal-title":"Eur. J. Gynaecol. Oncol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.152755_bb0430","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00726-018-2539-1","article-title":"Selection and identification of novel peptides specifically targeting human cervical cancer","volume":"50","author":"Liu","year":"2018","journal-title":"Amino Acids"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152755_bb0435","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00253-024-13058-w","article-title":"Advanced detection of cervical cancer biomarkers using engineered filamentous phage nanofibers","volume":"108","author":"Zhou","year":"2024","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152755_bb0440","doi-asserted-by":"crossref","DOI":"10.1038\/srep09382","article-title":"Design of a PDZbody, a bivalent binder of the E6 protein from human papillomavirus","volume":"5","author":"Karlsson","year":"2015","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.152755_bb0445","article-title":"CAR-T cells based on a TCR mimic nanobody targeting HPV16 E6 exhibit antitumor activity against cervical cancer","volume":"32","author":"Duan","year":"2024","journal-title":"Mol. Ther. Oncol."},{"key":"10.1016\/j.ijbiomac.2026.152755_bb0450","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.586796","article-title":"Immunodiagnosis and immunotherapeutics based on human papillomavirus for HPV-induced cancers","volume":"11","author":"Dong","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2026.152755_bb0455","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.molimm.2019.02.022","article-title":"Nanobody against the E7 oncoprotein of human papillomavirus 16","volume":"109","author":"Li","year":"2019","journal-title":"Mol. Immunol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.152755_bb0460","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1002\/cncr.26468","article-title":"Identification of novel immunogenic human leukocyte antigen-A* 2402-binding epitopes of human papillomavirus type 16 E7 for immunotherapy against human cervical cancer","volume":"118","author":"Jang","year":"2012","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.152755_bb0465","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jncc.2024.11.006","article-title":"Global burden of cervical cancer: current estimates, temporal trend and future projections based on the GLOBOCAN 2022","volume":"5","author":"Wu","year":"2025","journal-title":"Journal of the National Cancer Center"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.152755_bb0470","doi-asserted-by":"crossref","first-page":"853","DOI":"10.31557\/APJCP.2020.21.3.853","article-title":"Effectiveness of a health education program to improve knowledge and attitude towards cervical cancer and pap smear: a controlled community trial in Malaysia","volume":"21","author":"Romli","year":"2020","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152755_bb0475","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/dc.22817","article-title":"American society of cytopathology workload recommendations for automated pap test screening: developed by the productivity and quality assurance in the era of automated screening task force","volume":"41","author":"Elsheikh","year":"2013","journal-title":"Diagn. Cytopathol."},{"issue":"14","key":"10.1016\/j.ijbiomac.2026.152755_bb0480","doi-asserted-by":"crossref","first-page":"7969","DOI":"10.1073\/pnas.97.14.7969","article-title":"Direct selection of a human antibody fragment directed against the tumor T-cell epitope HLA-A1\u2013MAGE-A1 from a nonimmunized phage-Fab library","volume":"97","author":"Chames","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"176","key":"10.1016\/j.ijbiomac.2026.152755_bb0485","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005661","article-title":"Targeting the intracellular WT1 oncogene product with a therapeutic human antibody","volume":"5","author":"Dao","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.152755_bb0490","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41419-018-0824-2","article-title":"BAP31, a newly defined cancer\/testis antigen, regulates proliferation, migration, and invasion to promote cervical cancer progression","volume":"9","author":"Dang","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2026.152755_bb0495","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.01237","article-title":"Understanding the mechanisms of resistance to CAR T-cell therapy in malignancies","volume":"9","author":"Cheng","year":"2019","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.152755_bb0500","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1080\/21645515.2021.1913960","article-title":"The potential applications of T cell receptor (TCR)-like antibody in cervical cancer immunotherapy","volume":"17","author":"Dass","year":"2021","journal-title":"Hum. Vaccin. Immunother."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152755_bb0505","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.atherosclerosis.2013.01.044","article-title":"The safety of therapeutic monoclonal antibodies: implications for cardiovascular disease and targeting the PCSK9 pathway","volume":"228","author":"Catapano","year":"2013","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152755_bb0510","article-title":"Radioimmunotherapy: a specific treatment protocol for cancer by cytotoxic radioisotopes conjugated to antibodies","volume":"2014","author":"Kawashima","year":"2014","journal-title":"Sci. World J."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152755_bb0515","doi-asserted-by":"crossref","first-page":"D1","DOI":"10.1530\/EJE-15-0338","article-title":"Mass spectrometry and immunoassay: how to measure steroid hormones today and tomorrow","volume":"173","author":"Taylor","year":"2015","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ijbiomac.2026.152755_bb0520","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.coi.2021.04.009","article-title":"Major histocompatibility complex (MHC) class I and class II proteins: impact of polymorphism on antigen presentation","volume":"70","author":"Abualrous","year":"2021","journal-title":"Curr. Opin. Immunol."},{"issue":"17","key":"10.1016\/j.ijbiomac.2026.152755_bb0525","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.24413","article-title":"Therapeutic significance of targeting survivin in cervical cancer and possibility of combination therapy with TRAIL","volume":"9","author":"Nakamura","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijbiomac.2026.152755_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2022.105365","article-title":"Identification of human leukocyte antigen in precancerous and cancerous cervical lesions from Ecuadorian women","volume":"105","author":"Mora","year":"2022","journal-title":"Infect. Genet. Evol."},{"issue":"26","key":"10.1016\/j.ijbiomac.2026.152755_bb0535","doi-asserted-by":"crossref","first-page":"18218","DOI":"10.1074\/jbc.274.26.18218","article-title":"A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies","volume":"274","author":"de Haard","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152755_bb0540","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1146\/annurev.immunol.22.012703.104527","article-title":"Immunological memory to viral infections","volume":"22","author":"Welsh","year":"2004","journal-title":"Annu. Rev. Immunol."},{"issue":"16","key":"10.1016\/j.ijbiomac.2026.152755_bb0545","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1182\/blood-2010-07-299248","article-title":"An anti\u2013PR1\/HLA-A2 t-cell receptor\u2013like antibody mediates complement-dependent cytotoxicity against acute myeloid leukemia progenitor cells","volume":"117","author":"Sergeeva","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ijbiomac.2026.152755_bb0550","doi-asserted-by":"crossref","DOI":"10.1017\/erm.2012.2","article-title":"T-cell-receptor-like antibodies\u2013generation, function and applications","volume":"14","author":"Dahan","year":"2012","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.ijbiomac.2026.152755_bb0555","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3389\/fimmu.2017.00292","article-title":"Major histocompatibility complex (MHC) class I and MHC class II proteins: conformational plasticity in antigen presentation","volume":"8","author":"Wieczorek","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2026.152755_bb0560","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00548","article-title":"Fc-mediated antibody effector functions during respiratory syncytial virus infection and disease","volume":"10","author":"Van Erp","year":"2019","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.152755_bb0565","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/leu.2016.57","article-title":"Activity of 8F4, a T-cell receptor-like anti-PR1\/HLA-A2 antibody, against primary human AML in vivo","volume":"30","author":"Sergeeva","year":"2016","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.152755_bb0570","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.4049\/jimmunol.177.6.4187","article-title":"Antibody targeting to a class I MHC-peptide epitope promotes tumor cell death","volume":"177","author":"Wittman","year":"2006","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.152755_bb0575","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1158\/1535-7163.MCT-21-0115","article-title":"T-cell receptor mimic antibodies for cancer immunotherapy","volume":"20","author":"Duan","year":"2021","journal-title":"Mol. Cancer Ther."},{"issue":"21","key":"10.1016\/j.ijbiomac.2026.152755_bb0580","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1038\/sj.gt.3301570","article-title":"A phage display selected fab fragment with MHC class I-restricted specificity for MAGE-A1 allows for retargeting of primary human T lymphocytes","volume":"8","author":"Willemsen","year":"2001","journal-title":"Gene Ther."},{"issue":"20","key":"10.1016\/j.ijbiomac.2026.152755_bb0585","first-page":"5835","volume":"62","author":"Cohen","year":"2002","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.152755_bb0590","first-page":"3184","volume":"62","author":"Lev","year":"2002","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.152755_bb0595","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1158\/0008-5472.CAN-16-3247","article-title":"Development of a T-cell receptor mimic antibody against wild-type p53 for cancer immunotherapy","volume":"77","author":"Li","year":"2017","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.152755_bb0600","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4143\/crt.2005.37.6.319","article-title":"The role of HPV E6 and E7 oncoproteins in HPV-associated cervical carcinogenesis","volume":"37","author":"Yim","year":"2005","journal-title":"Cancer Res. Treat."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.152755_bb0605","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrc2355","article-title":"Adoptive cell transfer: a clinical path to effective cancer immunotherapy","volume":"8","author":"Rosenberg","year":"2008","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152755_bb0610","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1158\/1078-0432.CCR-07-1880","article-title":"Induction of tumor-specific CD4+ and CD8+ t-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine","volume":"14","author":"Welters","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"19","key":"10.1016\/j.ijbiomac.2026.152755_bb0615","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa0810097","article-title":"Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia","volume":"361","author":"Kenter","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152755_bb0620","article-title":"Human tumor antigens and cancer immunotherapy","volume":"2015","author":"Vigneron","year":"2015","journal-title":"Biomed. Res. Int."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.152755_bb0625","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133670","article-title":"Precise classification of cervical carcinomas combined with somatic mutation profiling contributes to predicting disease outcome","volume":"10","author":"Spaans","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152755_bb0630","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2018.29.e4","article-title":"Mutational analysis of KRAS and its clinical implications in cervical cancer patients","volume":"29","author":"Jiang","year":"2018","journal-title":"J. Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.152755_bb0635","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.ajps.2020.01.002","article-title":"TCR-mimic antibody-drug conjugates targeting intracellular tumor-specific mutant antigen KRAS G12V mutation","volume":"15","author":"Shen","year":"2020","journal-title":"Asian Journal of Pharmaceutical Sciences"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152755_bb0640","article-title":"Human leukocyte antigen (HLA) system: genetics and association with bacterial and viral infections","volume":"2022","author":"Medhasi","year":"2022","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.ijbiomac.2026.152755_bb0645","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2018.00113","article-title":"The role of Epstein\u2013Barr virus in cervical cancer: a brief update","volume":"8","author":"Vranic","year":"2018","journal-title":"Front. Oncol."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2026.152755_bb0650","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetimm.2005.04.006","article-title":"Viral interference with MHC class I antigen presentation pathway: the battle continues","volume":"107","author":"Ambagala","year":"2005","journal-title":"Vet. Immunol. Immunopathol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152755_bb0655","article-title":"Anti-melanoma activity of T cells redirected with a TCR-like chimeric antigen receptor","volume":"4","author":"Zhang","year":"2014","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.152755_bb0660","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.bbrc.2018.05.190","article-title":"Anti-viral immune response in the lung and thymus: molecular characterization and expression analysis of immunoproteasome subunits LMP2, LMP7 and MECL-1 in pigs","volume":"502","author":"Liu","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijbiomac.2026.152755_bb0665","doi-asserted-by":"crossref","DOI":"10.1177\/117727190600100015","article-title":"Biomarkers in cervical cancer","volume":"1","author":"Yim","year":"2006","journal-title":"Biomark. Insights"},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.152755_bb0670","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1155\/2007\/678793","article-title":"Biomarkers in cervical cancer screening","volume":"23","author":"Wentzensen","year":"2007","journal-title":"Dis. Markers"},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.152755_bb0675","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1002\/cncr.24293","article-title":"Sperm-associated antigen 9 is a biomarker for early cervical carcinoma","volume":"115","author":"Garg","year":"2009","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.152755_bb0680","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.4161\/onci.20686","article-title":"Cancer testis antigens: A new paradigm for cancer therapy","volume":"1","author":"Suri","year":"2012","journal-title":"Oncoimmunology"},{"issue":"18","key":"10.1016\/j.ijbiomac.2026.152755_bb0685","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1182\/blood-2011-04-348540","article-title":"Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias","volume":"118","author":"Brentjens","year":"2011","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.152755_bb0690","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1200\/JCO.2010.32.2537","article-title":"Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1","volume":"29","author":"Robbins","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"16","key":"10.1016\/j.ijbiomac.2026.152755_bb0695","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1215134","article-title":"Chimeric antigen receptor\u2013modified T cells for acute lymphoid leukemia","volume":"368","author":"Grupp","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.152755_bb0700","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1158\/1078-0432.CCR-14-1559","article-title":"Adoptive transfer of MAGE-A4 T-cell receptor gene-transduced lymphocytes in patients with recurrent esophageal cancer","volume":"21","author":"Kageyama","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.152755_bb0705","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.4049\/jimmunol.1001480","article-title":"CD8 controls T cell cross-reactivity","volume":"185","author":"Wooldridge","year":"2010","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.152755_bb0710","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.cell.2014.03.047","article-title":"Deconstructing the peptide-MHC specificity of T cell recognition","volume":"157","author":"Birnbaum","year":"2014","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.152755_bb0715","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.ymthe.2018.02.017","article-title":"Preclinical strategies to identify off-target toxicity of high-affinity TCRs","volume":"26","author":"Bijen","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ijbiomac.2026.152755_bb0720","article-title":"Prospective identification of cross-reactive human peptide-MHC ligands for T cell receptor based therapies","author":"Gejman","year":"2018","journal-title":"BioRxiv"},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.152755_bb0725","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/s41589-018-0130-4","article-title":"T cell receptor cross-reactivity expanded by dramatic peptide\u2013MHC adaptability","volume":"14","author":"Riley","year":"2018","journal-title":"Nat. Chem. Biol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.152755_bb0730","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/nbt.4282","article-title":"High-throughput determination of the antigen specificities of T cell receptors in single cells","volume":"36","author":"Zhang","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2026.152755_bb0735","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.iotech.2019.06.003","article-title":"T-cell-receptor cross-recognition and strategies to select safe T-cell receptors for clinical translation","volume":"2","author":"Bentzen","year":"2019","journal-title":"Immuno-Oncology and Technology"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152755_bb0740","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/s41592-018-0304-8","article-title":"T cell antigen discovery via signaling and antigen-presenting bifunctional receptors","volume":"16","author":"Joglekar","year":"2019","journal-title":"Nat. Methods"},{"issue":"suppl_2","key":"10.1016\/j.ijbiomac.2026.152755_bb0745","doi-asserted-by":"crossref","first-page":"W362","DOI":"10.1093\/nar\/gkl124","article-title":"ScanProsite: Detection of PROSITE signature matches and ProRule-associated functional and structural residues in proteins","volume":"34","author":"De Castro","year":"2006","journal-title":"Nucleic Acids Res."},{"issue":"197","key":"10.1016\/j.ijbiomac.2026.152755_bb0750","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006034","article-title":"Identification of a titin-derived HLA-A1\u2013presented peptide as a cross-reactive target for engineered MAGE A3\u2013directed T cells","volume":"5","author":"Cameron","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.152755_bb0755","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.immuni.2013.03.002","article-title":"Development and maintenance of regulatory T cells","volume":"38","author":"Ohkura","year":"2013","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.152755_bb0760","doi-asserted-by":"crossref","DOI":"10.1101\/pdb.prot099689","article-title":"Fixing attached cells for staining","volume":"2020","author":"Rodig","year":"2020","journal-title":"Cold Spring Harb. Protoc."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026026826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026026826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T16:35:40Z","timestamp":1790440540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026026826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":152,"alternative-id":["S0141813026026826"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.152755","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and characterization of novel T-cell receptor\u2013like antibodies targeting human papillomavirus type 16 oncoprotein peptides for early cervical cancer detection using experimental and computational approaches","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.152755","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"152755"}}